IP Library Granted Patent US 11,622,439
Granted Patent B2
US 11,622,439 · App. 17/409,552 · Granted Apr 4, 2023

Apparatus and methods for treatment using non-thermal plasma

Inventors: Bradley N. Eckert (Chandler, AZ); Huan Truong (Chandler, AZ); Bryon K. Eckert (Chandler, AZ)
Assignee: CHISCAN HOLDINGS, LLC
H05H1/2406A61B18/042H05H1/47H05H2240/20H05H2245/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,622,439
App. No.
17/409,552
Granted
Apr 4, 2023
Kind
B2
Abstract

An array of non-thermal plasma emitters is controlled to emit plasma based on application of an electric current at desired frequencies and a controlled power level. A power supply for an array controller includes a transformer that operates at the resonant frequency of the combined capacitance of the array and the cable connecting the array to the power supply. The power into the array is monitored by the controller and can be adjusted by the user. The controller monitors reflected power characteristics, such as harmonics of the alternating current, to determine initiation voltage of the plasma and/or resonant frequency plasma emitters. The array of non-thermal plasma emitters may be used in therapeutic, diagnostic, and/or medical sanitization applications, including where a non-thermal plasma treatment regimen is prescribed.

Claims (46)

1. A device, comprising:

a power supply;

an array electrically connected to the power supply, the array including:

a substrate,

a plurality of plasma emitters on the substrate, each plasma emitter in the plurality of plasma emitters configured to electrically ionize air to produce a non-thermal plasma, and

a memory device on the substrate, the memory device configured to store a prescription setting, the prescription setting identifying an operational attribute of the device; and

a controller in electronic communication with the array and the power supply, the controller being configured to:

receive the prescription setting from the memory device of the array, and

control the power supply in accordance with the prescription setting to modulate an alternating current transmitted to at least a first plasma emitter of the plurality of plasma emitters to cause the first plasma emitter to produce a first non-thermal plasma.

2. The device of claim 1 , wherein the power supply is electrically connected to the array by a cable and the controller is configured to:

measure a reflected power signal of the cable; and

based on the reflected power signal, modulate the power supply to set a constant plasma power level.

3. The device of claim 2 , wherein a first frequency of the reflected power signal is a second or higher-order harmonic frequency of a second frequency of the alternating current.

4. The device of claim 1 , wherein the prescription setting is associated with a power level of the alternating current and the controller is configured to control the power supply to generate the alternating current at the power level.

5. The device of claim 1 , wherein the prescription setting is associated with a treatment duration and the controller is configured to further control the power supply in accordance with the prescription setting to generate the alternating current for a time period that does not exceed the treatment duration.

6. The device of claim 1 , wherein the controller is configured to store a parameter of an operation of the controller in the memory device of the array.

7. The device of claim 1 , wherein the memory device stores an identification code and the controller is configured to:

receive the identification code from the memory device; and

before controlling the power supply in accordance with the prescription setting, determine that the identification code indicates that the array is authorized for use.

8. A device, comprising:

an array including:

a substrate, and

a plasma emitter on the substrate;

a cable configured to electrically connect a power supply to the array;

a memory device associated with the array, the memory device storing a prescription setting; and

a controller comprising a port for connecting to the array via the cable, the controller configured to:

receive the prescription setting from the memory device, and

control a power supply in accordance with the prescription setting to modulate an alternating current transmitted to the plasma emitter in accordance with the prescription setting.

9. The device of claim 8 , wherein the controller is configured to determine a reflected power signal of the cable.

10. The device of claim 9 , wherein a first frequency of the reflected power signal is a second or higher-order harmonic frequency of a second frequency of the alternating current.

11. The device of claim 8 , wherein the prescription setting is associated with a frequency setting and the controller is configured to control the power supply to generate plasma at the plasma emitter, wherein a frequency of the plasma is the same as the frequency setting.

12. The device of claim 8 , wherein the prescription setting is associated with a treatment duration and the controller is further configured to control the power supply in accordance with the prescription setting to generate the alternating current for a time period that does not exceed the treatment duration.

13. The device of claim 8 , wherein the memory device is disposed on the substrate of the array.

14. The device of claim 13 , wherein the controller is configured to store a parameter of an operation of the controller in the memory device of the array.

15. The device of claim 13 , wherein the memory device stores an identification code and the controller is configured to:

receive the identification code from the memory device; and

determine that the identification code indicates that the cable is authorized for use.

16. A method, comprising:

receiving, by a controller of a plasma treatment device, a prescription setting from a memory device of an array, the array including a plurality of plasma emitters on a substrate; and

controlling, by the controller, a power supply in accordance with the prescription setting to modulate an alternating current transmitted to at least a first plasma emitter of the plurality of plasma emitters to cause the first plasma emitter to produce a first non-thermal plasma.

17. The method of claim 16 , wherein the power supply is electrically connected to the array by a cable, the method further comprising measuring, by the controller, a reflected power signal of the cable.

18. The method of claim 16 , wherein the prescription setting is associated with a power level of the alternating current, the method further comprising controlling, by the controller, the power supply to generate the alternating current at the power level.

19. The method of claim 16 , wherein the prescription setting is associated with a treatment duration, the method further comprising controlling, by the controller, the power supply in accordance with the prescription setting to generate the alternating current for a time period that does not exceed the treatment duration.

20. The method of claim 16 , wherein the memory device stores an identification code, the method further comprising:

receiving, by the controller, the identification code from the memory device; and

determining, by the controller, that the identification code indicates that the array is authorized for use.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2023
From: CHISCAN HOLDINGS, LLC
To: CHISCAN HOLDINGS PTE. LTD.
Reel/Frame 062865/0537 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2021
From: ECKERT, BRADLEY N.; TRUONG, HUAN; ECKERT, BRYON K.
To: CHISCAN HOLDINGS, L.L.C.
Reel/Frame 057533/0260 →
Continuity (8)
Continuation 16896136 · Jun 8, 2020
Continuation In Part 16233004 · Dec 26, 2018
Continuation 15787603 · Oct 18, 2017
Continuation 15213201 · Jul 18, 2016
Continuation In Part 15055028 · Feb 26, 2016
Provisional Application 63007931 · Apr 9, 2020
Provisional Application 62235517 · Sep 30, 2015
Related Publication 20210385933A1 · Dec 9, 2021